APA

Friedlaender A., Vuilleumier A., Viassolo V., Ayme A., De Talhouet S., Combes J., Peron J., Bodmer A., Giraud S., Buisson A., Bonadona V., Gauchat-Bouchardy I., Tredan O., Chappuis P. O. & Labidi-Galy S. I. (20190716). BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. : Breast cancer research and treatment.

Chicago

Friedlaender Alex, Vuilleumier Aurélie, Viassolo Valeria, Ayme Aurélie, De Talhouet Solène, Combes Jean-Damien, Peron Julien, Bodmer Alexandre, Giraud Sophie, Buisson Adrien, Bonadona Valerie, Gauchat-Bouchardy Isabelle, Tredan Olivier, Chappuis Pierre O and Labidi-Galy S Intidhar. 20190716. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. : Breast cancer research and treatment.

Harvard

Friedlaender A., Vuilleumier A., Viassolo V., Ayme A., De Talhouet S., Combes J., Peron J., Bodmer A., Giraud S., Buisson A., Bonadona V., Gauchat-Bouchardy I., Tredan O., Chappuis P. O. and Labidi-Galy S. I. (20190716). BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. : Breast cancer research and treatment.

MLA

Friedlaender Alex, Vuilleumier Aurélie, Viassolo Valeria, Ayme Aurélie, De Talhouet Solène, Combes Jean-Damien, Peron Julien, Bodmer Alexandre, Giraud Sophie, Buisson Adrien, Bonadona Valerie, Gauchat-Bouchardy Isabelle, Tredan Olivier, Chappuis Pierre O and Labidi-Galy S Intidhar. BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients. : Breast cancer research and treatment. 20190716.